Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 2Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasms 4Head and Neck Neoplasms 3Pain 2Depression 2Breast Neoplasms 2Stomatitis 1Pancreatic Neoplasms 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Cancer Pain 1Anxiety Disorders 1Agnosia 1

Interventions

Trastuzumab 304Paclitaxel 257Cyclophosphamide 251Docetaxel 238Capecitabine 176Letrozole 163Carboplatin 163Fulvestrant 145Doxorubicin 145Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 89Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 45Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Ketamine × Clear all
NCT04275661 2026-02-04

Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery

Assiut University

Phase 2 Completed
60 enrolled
Breast

Agnosia, Breast Neoplasms

NCT00304850 2009-12-29

PoLyDOL

University Hospital, Bordeaux

Phase 2 Completed
160 enrolled
Breast

Breast Neoplasms, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡